The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of envafolimab plus lenvatinib combined with TACE in unresectable hepatocellular carcinoma: An open-label, single-arm, phase 2 study—The CISLD-12 study.
 
Tingbo Liang
No Relationships to Disclose
 
Yiwen Chen
No Relationships to Disclose
 
Xin Huang
No Relationships to Disclose
 
Wendi Hu
No Relationships to Disclose
 
Xiang Li
No Relationships to Disclose
 
Junhui Sun
No Relationships to Disclose
 
Yan Shen
No Relationships to Disclose
 
Min Zhang
No Relationships to Disclose
 
Jian Wu
No Relationships to Disclose
 
Shunliang Gao
No Relationships to Disclose
 
Jun Yu
No Relationships to Disclose
 
Risheng Que
No Relationships to Disclose
 
Yun Zhang
No Relationships to Disclose
 
Fuchun Yang
No Relationships to Disclose
 
Weiliang Xia
No Relationships to Disclose
 
Aibin Zhang
No Relationships to Disclose
 
Xiaofeng Tang
No Relationships to Disclose
 
Xueli Bai
No Relationships to Disclose